Skip to main content
The FiscalWire

VERA

NASDAQ-GM

Vera Therapeutics, Inc. Class A Common Stock

$33.05
-3.21 (-8.85%)

Key Statistics - VERA

Valuation Measures

MetricCurrent
Market Cap2.38B
Enterprise Value0
Trailing P/E
Forward P/E
PEG Ratio (5yr expected)
Price/Sales
Price/Book5.83
EV/Revenue
EV/EBITDA

Financial Highlights

Fiscal Year

Fiscal Year Ends
Most Recent Quarter (mrq)

Profitability

Profit Margin
Operating Margin (ttm)

Management Effectiveness

Return on Assets (ttm)-72.32%
Return on Equity (ttm)-91.75%

Income Statement

Revenue (ttm)
Revenue Per Share (ttm)
Quarterly Revenue Growth (yoy)
Gross Profit (ttm)
EBITDA
Net Income Avi to Common (ttm)
Diluted EPS (ttm)-5.87
Quarterly Earnings Growth (yoy)-27.01%

Balance Sheet

Total Cash (mrq)
Total Cash Per Share (mrq)6.93
Total Debt (mrq)
Total Debt/Equity (mrq)0.18
Current Ratio (mrq)10.65
Book Value Per Share (mrq)5.67

Cash Flow Statement

Operating Cash Flow (ttm)
Levered Free Cash Flow (ttm)

Trading Information

Stock Price History

Beta (5Y Monthly)1.04
52 Week Change
S&P500 52-Week Change
52 Week High56.05
52 Week Low23.05
50-Day Moving Average0.00
200-Day Moving Average0.00

Share Statistics

Avg Vol (3 month)2.46M
Avg Vol (10 day)0
Shares Outstanding71.96M
Implied Shares Outstanding71.96M
Float58.51M
% Held by Insiders18.81%
% Held by Institutions98.38%
Shares Short
Short Ratio8.08
Short % of Float33.97%
Short % of Shares Outstanding
Shares Short (prior month)

Dividends & Splits

Forward Annual Dividend Rate
Forward Annual Dividend Yield
Trailing Annual Dividend Rate
Trailing Annual Dividend Yield
5 Year Average Dividend Yield
Payout Ratio
Dividend Date
Ex-Dividend Date
Last Split Factor
Last Split Date